Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
QOL
Axicabtagene Ciloleucel CAR-T Treatment Improved Quality of Life Over Standard of Care in R/R LBCL
Cecilia Brown
Aggressive B-Cell Lymphoma
|
November 22, 2022
Axicabtagene ciloleucel, an autologous anti-CD19 CAR T-cell treatment, improved quality of life compared to standard of care ...
Read More
Late Effects of Treatment Linked with QOL in Long-Term Lymphoma Survivors
Leah Lawrence
Hodgkin Lymphoma
|
November 14, 2022
Long-term lymphoma survivors who underwent transplant had impaired health-related quality of life.
Read More
Advertisement
Advertisement
Advertisement
Advertisement